The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Bone erosion 2
RITUXIMAB Brain oedema 2
RITUXIMAB Cardiomyopathy 2
RITUXIMAB Central nervous system lymphoma 2
RITUXIMAB Cerebral infarction 2
RITUXIMAB Chest pain 2
RITUXIMAB Cholecystitis infective 2
RITUXIMAB Cystitis haemorrhagic 2
RITUXIMAB Cytokine storm 2
RITUXIMAB Dermatitis 2
Rituximab Disseminated tuberculosis 2
RITUXIMAB Drug hypersensitivity 2
Rituximab Drug ineffective for unapproved indication 2
RITUXIMAB Dry skin 2
Rituximab Dysphagia 2
Rituximab Dyspnoea exertional 2
Rituximab Electrolyte imbalance 2
RITUXIMAB Encephalitis 2
RITUXIMAB Enterococcal infection 2
RITUXIMAB Enterocolitis infectious 2

Total Records: 1,104     Number of Pages: 56